|
|
|
| Effect of cognitive behavioral therapy assisted Sertraline on type 2 diabetes mellitus patients combined with depression |
| ZHANG Hongyan1 ZHANG Yuping2 ZHANG Yanjiao1 ZHENG Jingjing1 BIAN Rui1 WANG Qina3 LI Wenhui4 REN Weidong5 |
1.The Third Department of Neurology, the First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075000, China;
2.Department of Pathophysiology, College of Basic Medicine, Hebei North University, Hebei Province, Zhangjiakou 075000, China;
3.United Front Department of Publicity, the First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075000, China;
4.Department of Cardiovascular Medicine, the Second Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075100, China;
5.Department of Endocrinology, the First Affiliated Hospital of Hebei North University, Hebei Province, Zhangjiakou 075000, China |
|
|
|
Abstract Objective To investigate the effect of cognitive behavioral therapy assisted Sertraline on type 2 diabetes mellitus patients combined with depression. Methods Sixty patients with type 2 diabetes mellitus patients combined with depression admitted to the First Affiliated Hospital of Hebei North University from January 2019 to December 2020 were selected, and they were divided into control group (30 cases) and experimental group (30 cases) according to the random number table method. The control group took Sertraline Hydrochloride Tablets orally, experimental group was given cognitive behavioral therapy on the basis of control group, and the course of treatment was eight weeks. The clinical efficacy was compared between two groups; the heart rate variability (HRV), fasting insulin (FINS), fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), homeostasis model assessment of insulin resistance (HOMA-IR), C-reactive protein (CRP), and total score of Hamilton depression scale (HAMD) were compared between two groups before and after treatment. Results There were four cases dropped out of control group and two cases dropped out of experimental group. The clinical efficacy of experimental group was better than that of control group, and the difference was statistically significant (P＜0.05). Intertemporal population standard deviation of HPV change (SDNN), the mean square root mean square difference of successive sinus R-R intervals of parasympathetic activity (rMSSD), the standard deviation of successive interval difference of parasympathetic accommodation (SDSD), and the high frequency power for parasympathetic modulatory capacity (HF) were higher than those before treatment, low-frequency power for sympathetic activity predominant (LF) and LF/HF were lower than those before treatment, and the differences were statistically significant (P＜0.05); the SDNN, rMSSD, SDSD, and HF of experimental group were higher than those of control group, and LF and LF/HF were lower than those of control group, and the differences were statistically significant (P＜0.05). After treatment, FINS, FBG, HOMA-IR, total score of HAMD, and CRP of two groups were lower than those before treatment, and those of experimental group were lower than those of control group, and the differences were statistically significant (P＜0.05). There was no significant difference in HbA1c between two groups before and after treatment (P＞0.05). Conclusion Cognitive behavioral therapy assisted Sertraline is more effective in the treatment of type 2 diabetes mellitus patients combined with depression, and it has better improvement on HRV, blood glucose, insulin function, and CRP.
|
|
|
|
|
|
[1] 孟君.老年2型糖尿病抑郁状态与患者衰弱及血糖控制的相关性[J].中国健康心理学杂志，2021，29（10）：1545- 1549.
[2] 郭玫，黄燕飞，刘瑛.老年糖尿病患者抑郁状况与不同量表测定生活质量之间的关系[J].中国老年学杂志，2020， 40（12）：2655-2659.
[3] 张丽，孔晓明，孙艳，等.老年2型糖尿病合并抑郁症患者血糖波动及临床症状的研究[J].中国糖尿病杂志，2022， 30（8）：584-587.
[4] 李梦凡，厉雪艳，梁冰.2型糖尿病患者伴发焦虑抑郁现状及其影响因素分析[J].中华全科医学，2021，19（7）：1135- 1137，1146.
[5] 李辛未.老年患者合并应用抗抑郁药情况调查分析及其药学监护[D].太原：山西医科大学，2018.
[6] 黄丽荣.精神科药物不良反应分析[J].临床合理用药杂志，2021，14（1）：108-109.
[7] 杜昊，张平.团体认知行为治疗对伴发焦虑抑郁的糖尿病患者的疗效[J].上海预防医学，2020，32（7）：582-586.
[8] 阙建宇，陈斯婧，邓佳慧，等.失眠认知行为治疗在精神障碍中的应用[J].中华行为医学与脑科学杂志，2022，31（1）：82-88.
[9] Hadinia A，Meyer A，Nowak K，et al. Cognitive Behavioral Therapy for Anxiety and Depression in Patients with Parkinson's Disease [J]. Fortschr Neurol Psychiatr，2016，84（6）：336- 343.
[10] 姚翡，郁秋荣，孔颖宏，等.2型糖尿病合并抑郁患者炎性因子和胰岛素抵抗指数的变化及其临床意[J].中国糖尿病杂志，2016，24（2）：104-107.
[11] 蔡胤浩，张亚华，范良敏.老年2型糖尿病合并抑郁症患者炎症因子及胰岛素抵抗与抑郁严重程度的关系[J].中国老年学杂志，2015，11（35）：6577-6578.
[12] 周英智，马丽娜，冯明.抑郁症对老年2型糖尿病患者心率变异性的影响[J].精神医学杂志，2013，26（1）：9- 11.
[13] 邸云翔，王艺明.抑郁症患者心脏自主神经功能变化及脑电非线性分析[J].中华行为医学与脑科学杂志，2017， 26（5）：411-415.
[14] Carney RM，Freedland KE，Steinmeyer B，et al. Cardiac risk mark-ers and response to depression treatment in patients with coronary heart disease [J]. PsychosomMed，2016，78（1）：49-59. DOI：10.1097/PSY.0000000000000245.
[15] 张明园，何燕玲.精神科评定量表手册[M].长沙：湖南科学技术出版社，2015：143-148，181-183.
[16] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）[J].中国实用内科杂志，2018，38（4）：292- 344.
[17] Messent P. DSM-5 [J]. Clin Child Psychol Psychiatry，2013，18（4）：479-482. DOI：10.1177/1359104513502138.
[18] 喻东山.减分率公式的修正[J].临床精神医学杂志，1995（1）：12.
[19] 张霞，李云霞，张艳，等.疏肝解郁胶囊与舍曲林治疗老年轻中度抑郁症对照研究[J].中国医药导报，2020，17（32）：116-119.
[20] 庞兆烽，徐武华，吴婉霞，等.甜梦胶囊联合盐酸舍曲林片治疗脑卒中后抑郁症的效果[J].中国医药导报，2020， 17（2）：65-68.
[21] 林翔，房圆，李霞.老年人抑郁症与认知障碍的鉴别诊断和临床诊治[J].中华老年医学杂志，2017，36（1）：12- 13.
[22] 李献云.认知行为治疗在精神科的价值[J].神经疾病与精神卫生，2017，17（2）：77-81.
[23] Beck JS，Beck AT. Cognitive behavior therapy：basics and beyond（2nd ed）[M]. New YorK：The Guilford press，2011：1-16.
[24] Wampold BE，Flückiger C，Del Re AC，et al. In pursuit of truth：A critical examination of meta-analyses of cognitive behavior therapy [J]. Psychother Res，2017，27（1）：14-32.
[25] 邹亮，张新功，孙丽丽，等.草酸艾司西酞普兰与舍曲林分别联合认知行为治疗青少年抑郁症的临床对照研究[J].中国医药导报，2021，18（13）：141-144.
[26] 杨璐璐，康尹之，张菀凌，等.网络化认知行为治疗在失眠障碍中的应用和研究进展[J].2020，40（1）：142-146.
[27] 高见，王鹏狮，李占江.认知行为治疗的生物学机制[J].心理科学进展，2019，27（3）：522-532.
[28] 苏金哥，姜海军，刘晓梅.药物联合认知行为治疗复发性抑郁障碍的效果[J].中国当代医药，2021，28（21）：55- 58.
[29] 苏金哥，刘晓梅，姜海军，等.联合认知行为疗法在复发性抑郁障碍治疗中的应用效果[J].中国医药科学，2021， 11（7）：234-236.
|
|
|
|
